Related Experiment Video
Updated: Aug 13, 2026

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
Published on: May 10, 2016
Children's acetaminophen exposures reported to a regional poison control center
Mallik V Angalakuditi1, Kim C Coley, Edward P Krenzelok
1School of Pharmacy, University of Pittsburgh, Pittsburgh, PA 15261, USA. hydmallik02@hotmail.com
Insights
Most acetaminophen exposures in children under six were unintentional, while older children (over 12) experienced intentional overdoses. This highlights differing acetaminophen exposure patterns by age group.
Area of Science:
- Toxicology
- Pediatric Emergency Medicine
- Public Health
Background:
- Acetaminophen is a common over-the-counter medication for pain and fever.
- Accidental and intentional overdoses in children pose significant health risks.
- Understanding exposure patterns is crucial for prevention and intervention.
Purpose of the Study:
- To analyze patient characteristics, doses, and exposure types in pediatric acetaminophen ingestions.
- To investigate age-specific trends in acetaminophen-related exposures reported to a regional poison control center.
Main Methods:
- Retrospective review of acetaminophen exposures in children (<18 years) from 2000-2003.
- Categorization of children into three age groups: <6 years, 6-12 years, and 13-17 years.
- Collection of demographic, drug, exposure type, and caller data.
Main Results:
- Acetaminophen exposures were most frequent in children under six (76%).
- Unintentional ingestions predominated in younger children (<12 years).
- Intentional overdoses were prevalent in adolescents (13-17 years, 91%), particularly females, with high doses (>200 mg/kg) reported in 47%.
Conclusions:
- Pediatric acetaminophen exposures show distinct age-related patterns.
- Younger children are more prone to unintentional ingestions.
- Adolescents, especially females, are at higher risk for intentional acetaminophen overdoses.
Purpose:
The patient characteristics, doses taken, and types of exposures in children with acetaminophen-related exposures reported to a regional poison control center (RPCC) were studied.
Methods:
A retrospective review was conducted of all acetaminophen exposures that occurred between October 31, 2000, and October 31, 2003, in children younger than 18 years who were managed by an RPCC. Children were grouped into three age categories: less than 6 years (group 1), 6-12 years (group 2), and 13-17 years (group 3). Data collected included patient demographics, drug details, type of exposure, time since exposure, exposure site, and caller site.
Results:
There were 473 exposures to acetaminophen: 76% in group 1, 3% in group 2, and 21% in group 3. Sex was distributed equally among groups, except group 3 was 83% females. The majority of callers seeking information on acetaminophen ingestion in children younger than 12 years were family members (62%), whereas health professionals (61%) were the most common callers for children over 12 years. Unintentional ingestion was the most common type of exposure in group 1 (100%) and group 2 (93.7%). In group 3, intentional ingestions were more common (91%), with females representing far more of these exposures than males (87% versus 14%, respectively). Acetaminophen doses over 200 mg/kg were ingested by 47% of children in group 3.
Conclusion:
Most acetaminophen exposures reported to an RPCC occurred in children less than six years of age and were unintentional, whereas exposures in children over 12 years were more likely to be intentional overdoses.
Related Concept Videos
Pharmaceutical Poisoning: Potential Scenarios
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Pharmaceutical Poisoning: Treatment Strategies